Journal
CANCER INVESTIGATION
Volume 37, Issue 3, Pages 144-155Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/07357907.2019.1582060
Keywords
Glioblastoma; Cancer stem cells; Dynamin; Cancer biology; Invasion
Categories
Funding
- Royal Melbourne Hospital Neuroscience Foundation
- ARC Discovery Project
- NHMRC Project grant
Ask authors/readers for more resources
Glioma stem cells (GSCs) play major roles in drug resistance, tumour maintenance and recurrence of glioblastoma. We investigated inhibition of the GTPase dynamin 2 as a therapy for glioblastoma. Glioma cell lines and patient-derived GSCs were treated with dynamin inhibitors, Dynole 34-2 and CyDyn 4-36. We studied about cell viability, and GSC neurosphere formation in vitro and orthotopic tumour growth in vivo. Dynamin inhibition reduced glioblastoma cell line viability and suppressed neurosphere formation and migration of GSCs. Tumour growth was reduced by CyDyn 4-36 treatment. Dynamin 2 inhibition therefore represents a novel approach for stem cell-directed Glioblastoma therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available